KIMBERLY HADDOCK: Open Payments
NPI 1922831916 · TARBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$222 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $18 · 2025 $222
Food & beverage: $222
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $75 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| PFIZER INC. | 2 | $32 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
| Amgen Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 2 | $12 |
Products named: Wegovy, TRELEGY ELLIPTA, PREVNAR 20, ZENPEP, Ozempic, Rybelsus, XIFAXAN, LEQVIO.
Industry payments across NC — which companies pay providers there.
